Rapid Medical
Carmel building P.O.B. 337
Yokneam
20692
Tel: 972-72-2503331
Fax: 972-72-2503332
Website: http://www.rapid-medical.com/
22 articles about Rapid Medical
-
Rapid Medical™ Announces Japanese Approval and Exclusive Partnership With Kaneka for TIGERTRIEVER–The World’s Only Adjustable Thrombectomy Device
12/13/2023
Rapid Medical™, a leading developer of advanced neurovascular devices, announced Japanese approval for its TIGERTRIEVER revascularization device.
-
Rapid Medical™ Gains Approval in China for the World’s Only Adjustable Thrombectomy Device
8/31/2023
Rapid Medical™, a leading developer of advanced neurovascular devices, announced Chinese approval for its TIGERTRIEVER revascularization device.
-
New Data Shows Advantages of Rapid Medical’s COMANECI™ Embolization Assist Device
7/19/2023
Rapid Medical™, a leading developer of advanced neurovascular devices, today announced new clinical data showing significant advantages of its novel COMANECI™ embolization assist device over established techniques to treat ruptured wide-neck intracranial aneurysms.
-
Rapid Medical Gains FDA Clearance for the Smallest & Only Adjustable Thrombectomy Device
7/26/2022
Rapid Medical, a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER™13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto.
-
Rapid Medical Marks First Procedures with Numen™ Coil from MicroPort Scientific
6/28/2022
Rapid Medical, a leading developer of advanced neurovascular devices, announces the expansion of its portfolio in the United States and the first Numen™ coil embolization procedure.
-
Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischemic Stroke Patient Population
6/2/2022
Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study.
-
Rapid Medical Announces Eitan Havis as International President
3/2/2022
Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International.
-
Rapid Medical Receives FDA Breakthrough Device Designation for Vasospasm Treatment
2/15/2022
Rapid Medical today announced FDA breakthrough designation for its Comaneci™ embolization assist device to facilitate the treatment of cerebral vasospasm following hemorrhagic stroke.
-
Rapid Medical to Initiate the First-Ever Trial to Expand Stroke Treatment to Distal Regions of the Brain–Offering Thrombectomy Treatment to New Patient Population
11/3/2021
Rapid Medical today announced FDA investigational device exemption (IDE) approval for the first-ever trial to expand interventional stroke treatment to distal regions of the brain.
-
Money on the Move: May 19-25
5/26/2021
Drug development requires solid funding. Here's who's standing on higher ground this week with fresh investment dollars. -
Rapid Medical Announces Appointment of James Romero as President, Americas
1/12/2021
Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas
-
Rapid Medical Receives FDA Clearance for the World’s First Steerable Neurovascular Guidewire
12/22/2020
Rapid Medical , a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces the FDA clearance of DRIVEWIRE, a novel guidewire with a steerable distal tip that handles complex anatomical turns with ease. This device is named Columbus outside of the United S
-
RAPID AI Enhanced Advanced Medical Imaging for Stroke Now Installed in Vietnam
12/17/2019
RAPID expands worldwide reach to bring Vietnam the only clinically validated, next-generation imaging platform for assessing stroke
-
Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
5/7/2019
Comaneci - the only non-vessel-occluding temporary intracranial coiling embolization assist device
-
Rapid Medical Raises $20 Million in New Funding to Support Clinical and Commercialization of First-in-class Stroke Treatment Products
4/23/2019
Rapid Medical, a company focused on the development of interventional neurovascular devices, announced today that it has completed an oversubscribed Series C financing of $20 million.
-
Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13
7/31/2018
The TIGERTRIEVER 13 is the smallest profile stentriever, designed to safely retrieve clots from intracranial vessels of 1mm - 2.5mm.
-
Rapid Medical: First Patient Enrolled to the TIGER Pivotal Clinical Study
5/16/2018
Data from the study will be submitted to the FDA in support of Market Clearance for TIGERTRIEVER in the U.S.
-
Rapid Medical: First Patient Enrolled To The TIGERTRIEVER Acute Ischemic Stroke Registry
9/19/2017
-
Shanghai-Israel Fund Co-Leads $9 Million Funding Of Rapid Medical
7/19/2017
-
Rapid Medical Snags $9 Million to Advance Commercialization of Stroke Products
7/17/2017